ライフサイエンスコーパス: blood plasma

1 n of a microRNA cancer biomarker (miR-16) in blood plasma.

2 ne falls below the minimal content of normal blood plasma.

3 SBF) with ionic composition similar to human blood plasma.

4 -cysteine (H-cys) with a DL of 43nM, even in blood plasma.

5 model mice intravenously injected with young blood plasma.

6 ties of individual fibrin fibers formed from blood plasma.

7 and specific fragmentation pattern in human blood plasma.

8 uld be detected in P. major feathers than in blood plasma.

9 s in human cerebrospinal fluid as well as in blood plasma.

10 e composition of biofluids such as urine and blood plasma.

11 in complex biological systems such as human blood plasma.

12 specific selectivity, in water and in human blood plasma.

13 f Hepatitis B virus antigen (HBsAg) in human blood plasma.

14 may be accompanied by a change in the RP of blood plasma.

15 of this protein has been described in human blood plasma.

16 rform direct isoelectric separation of human blood plasma.

17 nal grafts, in graft tissue and in recipient blood plasma.

18 derived from both normal and cancer patient blood plasma.

19 ENV), and West Nile (WNV) virus infection in blood plasma.

20 ral therapy (ART) with suppressed HIV RNA in blood plasma.

21 assay biosensor, measuring cTnI in undiluted blood plasma.

22 e complex lipid species diversity present in blood plasma.

23 s shed from the endothelial surface into the blood plasma.

24 ral therapy (ART) with suppressed HIV RNA in blood plasma.

25 V5 region of env from genital secretions and blood plasma.

26 s present in rat liver microsomes and bovine blood plasma.

27 alyses of Drosophila hemolymph and mammalian blood plasma.

28 tion of target analytes from undiluted human blood plasma.

29 mes and 24.0 (+/-1.5)% to 82.5 (+/-14.0)% in blood plasma.

30 ng, and levels of anti CMV immunoglobulin in blood plasma.

31 he cell free DNA (cfDNA) fraction of patient blood plasma.

32 its target in a complex media such as human blood plasma.

33 containing metabolites from cell lysates and blood plasma.

34 the profiling of biofluids such as urine and blood plasma.

35 in vitro by stability-measurements in human blood plasma.

36 ll as in the cerebrospinal fluid, but not in blood plasma.

37 ation of IL-1beta, IL-6, and TNFalpha in the blood plasma.

38 might not be the same as those emerging from blood plasma.

39 ted function as a major source of protons in blood plasma.

40 fouling of sensors by oxidation products in blood plasma.

41 pathway members were elevated in SDS patient blood plasma.

42 e organ that secretes bioactive factors into blood plasma.

43 rous small-molecule thiols and disulfides in blood plasma.

44 tive capture of MC-LR from aqueous media and blood plasma.

45 BRE capacity and resistance to fouling from blood plasma.

46 level of hemolysis by measuring the color of blood plasma.

47 ved in A1 domains of VWF multimers native to blood plasma.

48 ontology term extracellular space as part of blood plasma.

49 laboratory measurements (clinical labs) from blood plasma across several thousand mostly healthy indi

50 y, when acellular hemoglobin is diluted into blood plasma after red cell lysis, the disassembly pathw

51 ingivitis macaques could also be observed in blood plasma, although the effects at both compartments

52 ions in concentrations of these compounds in blood plasma, although the presence of various cyanidin

53 Objectives: To determine whether young blood plasma ameliorates pathology and cognition in a mo

54 ngival crevicular fluid consisting of 70% of blood plasma, an abundance of T. forsythia in the bacter

55 In blood plasma and cerebrospinal fluid (CSF), most protein

56 extracellularly in body fluids such as human blood plasma and cerebrospinal fluid (CSF).

57 cle used widely for sensing and delivery, in blood plasma and cerebrospinal fluid.

58 s were performed on samples of monocytes and blood plasma and correlated with magnetic resonance imag

59 ine OSCs in cooked garlic samples as well as blood plasma and digestive fluids.

60 m several types of undiluted media including blood plasma and food media.

61 Single viral templates from blood plasma and genital tract RNA and DNA were sequence

62 gnitude more abundant than (H(+))(aq) in the blood plasma and in the oceans.

63 an serum albumin (HSA) binds 95% of Abeta in blood plasma and is thought to inhibit plaque formation

64 essentially prevented peptide degradation in blood plasma and liver homogenates versus an unstapled c

65 creen in human subjects of the metabolome of blood plasma and saliva at different times of day.

66 phosphorylated alpha-syn can be detected in blood plasma and shows more promise as a diagnostic mark

67 can increase the level of HDL cholesterol in blood plasma and suppress the risk of cardiovascular dis

68 e to capture dengue-specific IgM antibody in blood plasma and the reverse, a blood plasma functionali

69 r constant (K(trans)) for gadolinium between blood plasma and tissue extravascular extracellular spac

70 spectrometry (HPLC-ICP-MS) analysis of mouse blood plasma and urine postadministration showed conside

71 NA during primary infection was cleared from blood plasma and urine within 10 d, viral RNA was detect

72 of the polymer brush coatings against human blood plasma and were surprised to find that coatings pr

73 ty in the genital tract (compared to that in blood plasma) and evidence of compartmentalization illus

74 oward the human GRPr, metabolic stability in blood plasma, and biodistribution in mice bearing GRPr-e

75 tide receptor (GRPr), metabolic stability in blood plasma, and biodistribution in mice bearing GRPr-e

76 lls (1.00+/-0.62 ng/g ww), whereas in liver, blood plasma, and brain all OPs were not detectable.

77 ts from fibrinogen, either in solution or in blood plasma, and could aggregate human platelets, eithe

78 man blood samples (whole blood, blood serum, blood plasma, and formed elements) was realized.

79 ood sample, EBV load was quantified in whole blood, plasma, and B cells using qPCR.

80 We measured lead in 81 maternal blood, plasma, and breast milk samples at 1 month postpa

81 dose-response relationships between maternal blood, plasma, and breast milk to better understand lact

82 turated FAs from various biological samples (blood, plasma, and cell lines).

83 ction in mice on the basis of their improved blood, plasma, and microsomal stability profiles compare

84 examine dose-response relationships between blood, plasma, and milk lead levels.

85 multiple biological specimens such as whole blood, plasma, and peritoneal dialysis effluent with cli

86 inactivated ZEBOV at known titers and whole-blood, plasma, and urine clinical specimens collected fr

87 Serial whole-blood, plasma, and urine samples were collected for radi

88 Serial whole blood, plasma, and urine samples were collected for radi

89 metabolite-corrected radioactivity in whole blood, plasma, and urine.

90 is without any sample preparation from dried blood, plasma, and urine.

91 Activity was determined in whole blood, plasma, and urine.

92 Metabolic profiling of blood plasma appears to be a promising approach for the

93 cross the day and that serotonin profiles in blood plasma are also rhythmic in LD, but were not rhyth

94 Although extracellular microRNAs in blood plasma are extensively characterized, extracellula

95 ion of several pathogenic bacterial cells in blood plasma around 30 min.

96 ariability of the (18)F-FDG concentration in blood plasma (arterial input function) was analyzed.

97 viral inoculation, viral RNA was detected in blood plasma as early as 1 d after infection.

98 ection without the need for preseparation of blood plasma as the nanometer-scale three-dimensional po

99 uspended in solutions much more viscous than blood plasma assume an almost steady-state orientation w

100 -reactive protein (CRP) and D-dimer in human blood plasma based on a white light interference spectro

101 hly sensitive LC-MS/MS multimethod for human blood plasma based on derivatization with o-phenylenedia

102 man with Zostavax, we sorted his circulating blood plasma blasts and amplified expressed immunoglobul

103 1 (HIV-1) RNA was measured in paired SP and blood plasma (BP) at baseline and after 1, 2, 4, 6, 8, 1

104 RNA was measured in seminal plasma (SP) and blood plasma (BP) at baseline, on days 3, 7, and 14, and

105 HIV-1 RNA was measured (LOQ 40 copies/mL) in blood plasma (BP), seminal plasma (SP), rectal fluid (RF

106 easured HIV-1 RNA in seminal plasma (SP) and blood plasma (BP), tenofovir (TFV) in SP and BP, and TFV

107 s quantified in seminal plasma (spVL) and in blood plasma (bpVL) from 2 paired samples collected 4 we

108 ficantly higher in P. major feathers than in blood plasma, but for most other PFAAs, these difference

109 The 9 major inorganic ions found in blood plasma (Ca(2+), Na(+), Mg(2+), K(+), H(+), Cl(-),

110 e detection limit for DMMP and PFOA in human blood plasma can be lowered by more than a factor of 2 i

111 t elevated levels of free cell hemoglobin in blood plasma can, as early as the first trimester, poten

112 plasma (M2) as well as infant umbilical cord blood plasma (CB).

113 In CSF supernatant and blood plasma, cell-free HIV RNA was quantified by qPCR w

114 Monoclonal antibodies derived from blood plasma cells of acute HIV-1-infected individuals a

115 ements of microliter sample volumes of human blood plasma coagulation (0.009 cP for viscosity range 0

116 env pyrosequencing data were generated from blood plasma collected from 7 individuals with evidence

117 high affinity and minimal interference from blood plasma components.

118 on performance as a function of its measured blood plasma concentration: it reduced reflection impuls

119 s attributed to the higher tumour uptake and blood plasma concentrations.

120 ensitivity and limit of detection (LOD) in a blood plasma-containing sample matrix.

121 The blood plasma contains four biologically important proteo

122 When biofilm lysine exceeds minimal blood plasma content after OHR, less GCF appeared despit

123 , unless biofilm lysine exceeded the minimal blood plasma content, in which case PI was further incre

124 strated on a panel of human biofluids (i.e., blood plasma, CSF, and urine) and brain tissue.

125 pes' and models for five biological systems: blood plasma, cytoplasm, synaptic vesicles, HIV and a my

126 Newborn blood plasma demonstrates substantially higher adenosine

127 Although numerous studies have characterized blood plasma-derived EVs from both uninfected and HIV-in

128 a induced a 50% decrease in triglycerides in blood plasma due to a reduced level of VLDL-secreted tri

129 l cell-free DNA (cfDNA) can be detected from blood plasma during fulminant infections such as sepsis.

130 een-blue to blue can be detected directly in blood plasma, even at picomolar concentrations of antibo

131 to estimate PFOA and PFOS concentrations in blood plasma, except when there is a great deal of varia

132 Here we use immunoassays to examine blood plasma expression patterns of Keratin 9 and its re

133 LC/MS of blood plasma extracts from rats that were administered a

134 lar extravascular volume fraction, v(e); and blood plasma fraction, v(p)) were determined by fitting

135 Between 2006 and 2011 we collected blood plasma from 261 bald eagle nestlings in six study

136 We compared blood plasma from 72 healthy controls with that from 88

137 jugate hydrolysis in maternal urine and cord blood plasma from a cohort of 181 expecting mother/infan

138 orms both the sample preparation (separating blood plasma from erythrocytes) and the assays; it also

139 HIV-1 and of 6 herpesviruses in seminal and blood plasma from HIV-1-infected and HIV-uninfected men.

140 Blood plasma from older adults undergoing elective surge

141 In fetal and maternal lungs, and in maternal blood plasma from pregnant rats exposed to environmental

142 t sequencing of reverse-transcribed RNA from blood plasma from three of nine colobus monkeys yielded

143 array and qPCR, and incubation of VSMCs with blood plasma from zinc-deficient rats strongly changed t

144 antibody in blood plasma and the reverse, a blood plasma functionalized surface to capture DENV-2.

145 acids such as siRNA while providing enhanced blood plasma half-life and tumor targeting.

146 Detection of PrP(C) in spiked blood plasma has been achieved and demonstrated a recove

147 Detection of PrP(C) in spiked blood plasma has been achieved in the same range of conc

148 SERS detection of Microcystin-LR (MC-LR) in blood plasma has been developed.

149 In a subanalysis of 100 subjects with blood plasma HIV <50 copies/mL, high levels of CMV in se

150 hort, and on the subset of 100 subjects with blood plasma HIV <50 copies/mL.

151 ve sex with men, who were receiving ART with blood plasma HIV <500 copies/mL.

152 t Dx assay (Aptima assay) is FDA cleared for blood plasma HIV-1 RNA quantitation.

153 The blood plasma ibuprofen sodium concentrations achieved in

154 to profile the time course of 263 lipids in blood plasma in 20 healthy individuals.

155 the target-bound AGO2 can be recovered from blood plasma in an ~1:1 ratio with the respective miRNA.

156 report a concentration factor of 10 in human blood plasma in continuous flow at a flow rate of 15 muL

157 n aquatic environments and representative of blood plasma in living organisms, respectively, on bioav

158 eover, dimeric alpha2M is generated in whole-blood plasma in the presence of physiologically relevant

159 he siRNA nanoparticles do not disassemble in blood plasma in vitro and in vivo.

160 cture of hydrated fibrin clots made of human blood plasma in vitro.

161 es for pure hemoglobin and for hemoglobin in blood plasma, in urine, in erythrocytes, and in full blo

162 ability of blood vessels is that exposure to blood plasma increases bone marrow HSPC ROS levels, augm

163 al inflammatory cytokine gene expression and blood plasma interleukin-6 levels were not influenced.

164 l inflammatory cytokine gene expression, and blood plasma interleukin-6 values were assessed.

165 tive level, systemic administration of young blood plasma into aged mice improved age-related cogniti

166 Lipidomics of human blood plasma is an emerging biomarker discovery approach

167 Relaxivity of [Mn(PyC3A)(H2O)](-) in blood plasma is comparable to commercial Gd contrast age

168 The tracer enrichment determination in blood plasma is demonstrated for several triple combinat

169 Although most circulating iron in blood plasma is destined for erythropoiesis, the mechani

170 Proteomic characterization of blood plasma is of central importance to clinical proteo

171 Serotonin in blood plasma is primarily synthesized in the duodenum, a

172 ecially towards the toxic (S)-enantiomer) in blood plasma is still desirable.

173 Blood plasma is the most popularly used sample matrix fo

174 eport that Cl(-), the most abundant anion in blood plasma, is a key component of Cp catalysis.

175 Intravitreal injections of autologous blood, plasma kallikrein (PK), bradykinin, and collagena

176 amine the relationship between pericytes and blood plasma leakage during photothrombotic occlusion of

177 PAS600-IL-1Ra displayed markedly extended blood plasma levels 3 days post-administration, whereas

178 l fluid (CSF) levels of FGLs correlated with blood plasma levels in rats and non-human primates, and

179 At the same consultations blood plasma levels of estradiol (E2) and thyroid hormon

180 he most important in the periodic table with blood plasma levels of H(+), Na(+) and Ca(2+) being indi

181 HPC blood plasma levels were also compared to known in vitro

182 lin in the brain are severalfold higher than blood plasma levels.

183 Doses were titrated to reach blood/plasma levels comparable to therapeutic levels in

184 thylphenidate and amphetamine at therapeutic blood/plasma levels during peri-adolescence in non-human

185 t sample preparation protocols for optimized blood plasma lipid extraction and measurement by UPLC-MS

186 cs the composition of interstitial fluid and blood plasma, LJM-3064 rapidly switches to a parallel-st

187 high stability in mouse liver microsomes and blood plasma, low intrinsic microsome clearance, and low

188 stable species without affecting other blood/blood plasma metabolites.

189 f (18)F-FDG concentration in lung tissue and blood plasma) might be an alternative to dynamic (18)F-F

190 Superoxide dismutase activity in human blood plasma mirrored these reductions between prospecti

191 However, both soluble mannose and blood plasma more strongly inhibited antibody recognitio

192 a genome-wide association study of the human blood plasma N-glycome composition in up to 3811 people

193 different lipid compositions and applying to blood plasma obtained from healthy individuals and from

194 istribution in cerebrospinal fluid (CSF) and blood plasma of 141 patients was measured with an immuno

195 ms in DIA data acquired from >200 samples of blood plasma of a human twin cohort and assessed the con

196 le for monitoring PFAA concentrations in the blood plasma of an insectivorous songbird model species,

197 further found to be dramatically elevated in blood plasma of individuals with CCRC compared with heal

198 d for the detection of misfolded proteins in blood plasma of patients with various subtypes of myelod

199 h transthyretin (TTR)-binding potency in the blood plasma of polar bear cubs were identified with eff

200 es where it normally does not occur, e.g. in blood plasma or in urine, is a sign of diseases such as

201 ty of the former two for FU determination in blood plasma or serum (~500 nM).

202 ccurate HIV incidence estimates using stored blood plasma or serum samples without a requirement for

203 dant proteins, which is usually performed on blood plasma or serum samples.

204 operate in complex biological fluids such as blood plasma or serum.

205 icantly (p < 0.05) correlated with levels in blood plasma; organophosphorus esters in brooches and wr

206 this study, we examined the role of EVs from blood plasma (pEVs) in an experimental autoimmune enceph

207 parabiosis) or repeated injections of young blood plasma (plasma from 2- to 3-month-old mice) into o

208 for fast in vivo acid-base reactivity in the blood plasma, possibly penetrating intact into membranes

209 A differentiation between the use of blood plasma powder and PPFG using the ratios of fibrino

210 Protein and proteome analysis of human blood plasma presents a challenge to current analytical

211 and suppress irreversible interactions with blood-plasma protein cocktails.

212 tionally, we quantified urinary excretion of blood plasma proteins alpha1-microglobulin, albumin, and

213 countered at sites of inflammation, converts blood plasma proteins into chaperone-like holdases that

214 This includes a predominant contribution of blood plasma proteins that is conserved with human SF.

215 ns, metabolic enzymes, some myofibrillar and blood plasma proteins were identified, which were charac

216 treatments, we recovered at least 82% of the blood plasma proteins, more than with state-of-the-art f

217 hundreds of proteins constituting the mouse blood plasma proteome, and upon their systemic administr

218 esting of nanoparticle-based technologies in blood plasma rather than the more ubiquitously tested se

219 tter characterize GDM in pregnant women, 100 blood plasma samples (50 GDM and 50 healthy pregnant con

220 rder to explore and seek differences between blood plasma samples acquired from NPC1 (untreated and m

221 Of 464 participants, 124 had insufficient blood plasma samples and 97 had no CMI grading (none, in

222 We detect CEA in three different blood plasma samples and demonstrate that this novel ref

223 for exhaustive lipid fingerprinting of human blood plasma samples based on the employment of methyl t

224 g Program using liquid biopsy in the form of blood plasma samples collected from 476 patients recruit

225 le full-genome de novo sequencing method for blood plasma samples collected from HIV-2-infected indiv

226 performed simultaneous TG and PG analysis in blood plasma samples from humans and 6 species commonly

227 chemometric techniques were used to analyze blood plasma samples from our cohort.

228 is approach is applied to study longitudinal blood plasma samples from prostate cancer patients, wher

229 Deep sequencing was applied to blood plasma samples from the cohort to detect cases of

230 tivity of blood-accumulating contaminants in blood plasma samples of approximately 4-months-old polar

231 n of antidepressant fluvoxamine in urine and blood plasma samples of obsessive-compulsive disorder (O

232 mployed to measure the NSE level in clinical blood plasma samples taken from deidentified TBI patient

233 For the latter case, blood plasma samples were analyzed by Fourier transform

234 n injury (TBI) protein biomarker, in diluted blood plasma samples, achieving a LOD of 0.86 ng/mL.

235 ed RNA-Seq to total RNA extracted from HIV-2 blood plasma samples, demonstrating the applicability of

236 sor has been developed to detect MG in human blood plasma samples.

237 onstrated using an artificially spiked human blood plasma samples.

238 d we demonstrate detection in actual patient blood plasma samples.

239 the evaluation of the lipid profile of human blood plasma samples.

240 ealthy uninfected controls in a total of 120 blood plasma samples.

241 HIV-1 RNA from blood plasma, seminal plasma, or cervical wicks was quan

242 logy we introduce a method for automation of blood plasma separation and multi-step bioassay procedur

243 The simple, portable blood plasma separation design is hand-driven and can ea

244 A portable, microfluidic blood plasma separation device is presented featuring a

245 We then simulated blood-plasma separation in arteriolar bifurcations with

246 The biosensor integrates membrane-based blood-plasma separation to develop lab-on-chip device th

247 ion that is able to perform highly efficient blood-plasma separation.

248 exploited for analysis of AFP in real human blood plasma, serum and urine sample.

249 say performance in complex media (i.e. whole blood, plasma, serum) due to the non-specific adsorption

250 MR)-based metabolic phenotyping of urine and blood plasma/serum samples provides important prognostic

251 lliliter level proteins in nondepleted human blood plasma/serum without affinity enrichment.

252 w abundance proteins (e.g., </= 100 pg/mL in blood plasma/serum) using targeted proteomics approaches

253 s effects of abundant proteins in the intact blood plasma/serum, which underscores the need for alter

254 a) tests were performed on fingerstick whole blood, plasma/serum, and CSF in 207 HIV-infected adults

255 Analysis of the duodenum and blood plasma showed that the amount of serotonin in the

256 da cheese) and biological samples (urine and blood plasma) signifying its potential as an alternative

257 on the exact metabolite compositions of the blood plasma, since the concept relies only on identifyi

258 inhibits PSD-95 and shows improved in vitro blood plasma stability.

259 uble plasma Fn (pFn), an abundant protein in blood plasma that is normally soluble and nonadhesive.

260 multiple differences between lymph fluid and blood plasma that may contribute to decreased oxidative

261 Thus, following analytical validation, in blood plasma, the technique was applied to a group of 59

262 s, can convert ethyl pyruvate to pyruvate in blood plasma, this additional source of extracellular py

263 uling from complex biological fluids such as blood plasma to biorecognition element (BRE)-functionali

264 res, addition of other drugs and addition of blood plasma to the colloidal suspensions.

265 investigated adsorption from undiluted human blood plasma to three different polymer brushes.

266 , suggesting that they are taken up from the blood plasma, together with yolk, during oocyte growth a

267 Here, blood plasma 'total alpha-synuclein' and 'Ser-129 phosph

268 Repetitive hind limb ischemia in rats-blood plasma transfers to isolated rat heart.

269 ain polyP can accelerate clotting of flowing blood plasma under flow at low to sub-physiological shea

270 oparticles within patient samples, including blood, plasma, urine and bronchoalveolar lavages.

271 biomarker carcinoembryonic antigen (CEA) in blood plasma using antibody against CEA and a surface pl

272 fibromyalgia) through the analysis of their blood plasma using attenuated total reflection Fourier-t

273 rring dengue NS1 antigen in infected patient blood plasma using straight long-range surface plasmon w

274 Optical determination of protamine in human blood plasma using the exhaustive nanosensors was attemp

275 eal-time and label-free manner in full human blood plasma, using ultra-high frequency acoustic wave s

276 icated that proteolytic hydrolysis of animal blood plasmas, using fungal protease preparations in par

277 Blood plasma viral loads and the time to progress to AID

278 pite similar baseline CD4(+) cell counts and blood plasma viral loads, women with subtype C had the h

279 Blood plasma volume was highly variable and the only par

280 d to quantify the BBB leakage rate and local blood plasma volume.

281 Cardioprotective properties of the blood plasma was investigated in the rat heart in vitro

282 Blood plasma was obtained, and organs were isolated typi

283 ween MOFs and biological milieu, human whole blood plasma was selected as a model.

284 Blood plasma was spiked with cholesterol.

285 ensors, total calcium concentration in human blood plasma was successfully determined.

286 Metabolic profiling of blood plasma was undertaken using proton nuclear magneti

287 Undiluted blood plasma was used to test the nonfouling properties

288 -free DNA (cfDNA), isolated from circulating blood plasma, we generated maps of genome-wide in vivo n

289 sity, density, and coagulation rate of human blood plasma were measured along with the standard coagu

290 Samples of monocytes and blood plasma were prospectively collected from healthy c

291 effective at triggering clotting of flowing blood plasma when localized on a surface than when solub

292 ected against phagocytic killing, whereas in blood plasma where the concentration of IgG is high, the

293 out 70x more abundant than (H(+))(aq) in the blood plasma, where we argue that its overall protonatio

294 ence of ADAMTS13 activity we also observe in blood plasma, which is relevant to predict hemostatic dy

295 investigated bradykinin-forming pathways in blood plasma with newly developed nanobody-based analyti

296 ows a good correlation in determining PCT in blood plasma with the clinically validated electrochemil

297 format in buffer and complex media (milk or blood plasma) with sub-nM detection ability.

298 ble of measuring vancomycin in buffer and in blood plasma within the range of 0.001-70 nM with a dete

299 n limit was observed to be 0.07 ng mL(-1) in blood plasma, without having any matrix effect, cross-re

300 n in humans and rodents has little effect on blood plasma zinc levels, and yet cellular consequences